Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

Fibrosis of the lung and other tissues: new concepts in pathogenesis and treatment.

Sime PJ, O'Reilly KM.

Clin Immunol. 2001 Jun;99(3):308-19. Review.

PMID:
11358425
2.

Molecular mechanisms of pulmonary fibrosis.

Pardo A, Selman M.

Front Biosci. 2002 Aug 1;7:d1743-61. Review.

PMID:
12133818
3.

Role of cytokines and cytokine therapy in wound healing and fibrotic diseases.

Gharaee-Kermani M, Phan SH.

Curr Pharm Des. 2001 Jul;7(11):1083-103. Review.

PMID:
11472255
4.

The role of eosinophils in pulmonary fibrosis (Review).

Gharaee-Kermani M, Phan SH.

Int J Mol Med. 1998 Jan;1(1):43-53. Review.

PMID:
9852197
5.

Re-evaluation of fibrogenic cytokines in lung fibrosis.

Kelly M, Kolb M, Bonniaud P, Gauldie J.

Curr Pharm Des. 2003;9(1):39-49. Review.

PMID:
12570673
6.

Transforming growth factor-beta and connective tissue growth factor: key cytokines in scleroderma pathogenesis.

Denton CP, Abraham DJ.

Curr Opin Rheumatol. 2001 Nov;13(6):505-11. Review.

PMID:
11698729
7.

Fibrosis, chronic inflammation and new pathways for drug discovery.

Sivakumar P, Das AM.

Inflamm Res. 2008 Sep;57(9):410-8. doi: 10.1007/s00011-008-7166-y. Review.

PMID:
18777113
8.

Transforming growth factor-beta: a mediator of cell regulation in acute respiratory distress syndrome.

Dhainaut JF, Charpentier J, Chiche JD.

Crit Care Med. 2003 Apr;31(4 Suppl):S258-64. Review.

PMID:
12682450
9.

CD40 signaling and Alzheimer's disease pathogenesis.

Town T, Tan J, Mullan M.

Neurochem Int. 2001 Nov-Dec;39(5-6):371-80. Review.

PMID:
11578772
10.

Idiopathic pulmonary fibrosis: molecular mechanisms and possible therapeutic strategies.

van den Blink B, Jansen HM, Peppelenbosch MP.

Arch Immunol Ther Exp (Warsz). 2000;48(6):539-45. Review.

PMID:
11197609
11.

Challenges in pulmonary fibrosis: 7--Novel therapies and lung transplantation.

Williams TJ, Wilson JW.

Thorax. 2008 Mar;63(3):277-84. doi: 10.1136/thx.2004.031054. Review.

PMID:
18308963
12.

Pulmonary fibrosis: cytokines in the balance.

Coker RK, Laurent GJ.

Eur Respir J. 1998 Jun;11(6):1218-21. Review.

13.

Cytokine regulation of pulmonary fibrosis in scleroderma.

Atamas SP, White B.

Cytokine Growth Factor Rev. 2003 Dec;14(6):537-50. Review.

PMID:
14563355
14.

How is Type I procollagen synthesis regulated at the gene level during tissue fibrosis.

Cutroneo KR.

J Cell Biochem. 2003 Sep 1;90(1):1-5. Review.

PMID:
12938150
15.

CD40 and vascular inflammation.

Urbich C, Dimmeler S.

Can J Cardiol. 2004 May 15;20(7):681-3. Review.

PMID:
15197419
16.

Pathogenesis of lung fibrosis and potential new therapeutic strategies.

McAnulty RJ, Laurent GJ.

Exp Nephrol. 1995 Mar-Apr;3(2):96-107. Review. No abstract available.

PMID:
7773645
17.

Pathogenesis of fibrosis: role of TGF-beta and CTGF.

Ihn H.

Curr Opin Rheumatol. 2002 Nov;14(6):681-5. Review.

PMID:
12410091
18.

Cytokine directed therapy in scleroderma: rationale, current status, and the future.

Simms RW, Korn JH.

Curr Opin Rheumatol. 2002 Nov;14(6):717-22. Review.

PMID:
12410097
19.

Transforming growth factor-beta signaling through the Smad proteins: role in systemic sclerosis.

Verrecchia F, Mauviel A, Farge D.

Autoimmun Rev. 2006 Oct;5(8):563-9. Epub 2006 Jul 5. Review.

PMID:
17027893
20.

Therapies for bleomycin induced lung fibrosis through regulation of TGF-beta1 induced collagen gene expression.

Cutroneo KR, White SL, Phan SH, Ehrlich HP.

J Cell Physiol. 2007 Jun;211(3):585-9. Review.

Supplemental Content

Support Center